Global mRNA Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global mRNA Vaccines market size was valued at US$ 9189 million in 2025 and is forecast to a readjusted size of US$ 19880 million by 2032 with a CAGR of 11.6% during review period.
In 2025, global mRNA vaccine production was about 1.1 billion doses with capacity near 2 billion doses per year; the average revenue per dose is USD 8, and innovator gross margins are around 62%. mRNA vaccines are biologic medicines that use messenger RNA (mRNA) molecules to instruct human cells to produce a harmless piece of a pathogen (such as a viral spike protein), which triggers an immune response without exposing the body to the actual disease. Their supply chain spans multiple specialized layers: upstream raw materials (nucleotides, enzymes, plasmid DNA templates, lipid components for lipid nanoparticles, buffers, and sterile consumables), midstream manufacturing (in-vitro transcription of mRNA, purification, lipid nanoparticle encapsulation, sterile fill-finish, and cold-chain packaging), and downstream distribution and deployment (ultra-cold storage logistics, regulatory release, healthcare delivery, and post-market pharmacovigilance). The ecosystem involves biotech innovators, contract development and manufacturing organizations (CDMOs), lipid and reagent suppliers, cold-chain logistics providers, and healthcare systems, making mRNA vaccines a highly integrated biopharmaceutical supply chain driven by rapid scalability, advanced materials, and stringent quality control.
The mRNA vaccine market is driven by pandemic preparedness policies, rapid platform scalability, and expanding applications beyond infectious diseases into oncology and rare diseases. Government funding, advance purchase agreements, and national biodefense strategies remain major demand anchors, while technological advantages such as faster development timelines, modular manufacturing, and strong IP protection support premium pricing and high margins. Growth is increasingly fueled by pipeline diversification (flu, RSV, combination vaccines, personalized cancer vaccines), improvements in lipid nanoparticle delivery and thermostability, and the build-out of regional manufacturing capacity to ensure supply security.
This report is a detailed and comprehensive analysis for global mRNA Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global mRNA Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global mRNA Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global mRNA Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global mRNA Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
mRNA Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe mRNA Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA Vaccines, with price, sales quantity, revenue, and global market share of mRNA Vaccines from 2021 to 2026.
Chapter 3, the mRNA Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and mRNA Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Vaccines.
Chapter 14 and 15, to describe mRNA Vaccines sales channel, distributors, customers, research findings and conclusion.
In 2025, global mRNA vaccine production was about 1.1 billion doses with capacity near 2 billion doses per year; the average revenue per dose is USD 8, and innovator gross margins are around 62%. mRNA vaccines are biologic medicines that use messenger RNA (mRNA) molecules to instruct human cells to produce a harmless piece of a pathogen (such as a viral spike protein), which triggers an immune response without exposing the body to the actual disease. Their supply chain spans multiple specialized layers: upstream raw materials (nucleotides, enzymes, plasmid DNA templates, lipid components for lipid nanoparticles, buffers, and sterile consumables), midstream manufacturing (in-vitro transcription of mRNA, purification, lipid nanoparticle encapsulation, sterile fill-finish, and cold-chain packaging), and downstream distribution and deployment (ultra-cold storage logistics, regulatory release, healthcare delivery, and post-market pharmacovigilance). The ecosystem involves biotech innovators, contract development and manufacturing organizations (CDMOs), lipid and reagent suppliers, cold-chain logistics providers, and healthcare systems, making mRNA vaccines a highly integrated biopharmaceutical supply chain driven by rapid scalability, advanced materials, and stringent quality control.
The mRNA vaccine market is driven by pandemic preparedness policies, rapid platform scalability, and expanding applications beyond infectious diseases into oncology and rare diseases. Government funding, advance purchase agreements, and national biodefense strategies remain major demand anchors, while technological advantages such as faster development timelines, modular manufacturing, and strong IP protection support premium pricing and high margins. Growth is increasingly fueled by pipeline diversification (flu, RSV, combination vaccines, personalized cancer vaccines), improvements in lipid nanoparticle delivery and thermostability, and the build-out of regional manufacturing capacity to ensure supply security.
This report is a detailed and comprehensive analysis for global mRNA Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global mRNA Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global mRNA Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global mRNA Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global mRNA Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for mRNA Vaccines
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
mRNA Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Conventional mRNA
- Self-amplifying mRNA
- Trans-amplifying mRNA
- Circular mRNA
- Standard IVT Platform Vaccines
- Modular Platform Vaccines
- Lyophilized mRNA Vaccines
- Single-antigen Vaccines
- Multivalent Vaccines
- Personalized Vaccines
- Infectious Diseases
- Autoimmune Diseases
- Cancers
- Others
- Moderna
- CureVac
- Sanofi
- BioNTech
- Sangamo Therapeutics
- Argos Therapeutics
- In-Cell-Art
- eTheRNA immunotherapies
- Ethris
- Tiba Biotechnology
- Pfizer
- Arcturus Therapeutics
- Genexine
- Translate Bio
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe mRNA Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA Vaccines, with price, sales quantity, revenue, and global market share of mRNA Vaccines from 2021 to 2026.
Chapter 3, the mRNA Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and mRNA Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Vaccines.
Chapter 14 and 15, to describe mRNA Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global mRNA Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Conventional mRNA
1.3.3 Self-amplifying mRNA
1.3.4 Trans-amplifying mRNA
1.3.5 Circular mRNA
1.4 Market Analysis by Platform Approach
1.4.1 Overview: Global mRNA Vaccines Consumption Value by Platform Approach: 2021 Versus 2025 Versus 2032
1.4.2 Standard IVT Platform Vaccines
1.4.3 Modular Platform Vaccines
1.4.4 Lyophilized mRNA Vaccines
1.5 Market Analysis by Antigen Strategy
1.5.1 Overview: Global mRNA Vaccines Consumption Value by Antigen Strategy: 2021 Versus 2025 Versus 2032
1.5.2 Single-antigen Vaccines
1.5.3 Multivalent Vaccines
1.5.4 Personalized Vaccines
1.6 Market Analysis by Application
1.6.1 Overview: Global mRNA Vaccines Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Infectious Diseases
1.6.3 Autoimmune Diseases
1.6.4 Cancers
1.6.5 Others
1.7 Global mRNA Vaccines Market Size & Forecast
1.7.1 Global mRNA Vaccines Consumption Value (2021 & 2025 & 2032)
1.7.2 Global mRNA Vaccines Sales Quantity (2021-2032)
1.7.3 Global mRNA Vaccines Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Moderna
2.1.1 Moderna Details
2.1.2 Moderna Major Business
2.1.3 Moderna mRNA Vaccines Product and Services
2.1.4 Moderna mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Moderna Recent Developments/Updates
2.2 CureVac
2.2.1 CureVac Details
2.2.2 CureVac Major Business
2.2.3 CureVac mRNA Vaccines Product and Services
2.2.4 CureVac mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 CureVac Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi mRNA Vaccines Product and Services
2.3.4 Sanofi mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sanofi Recent Developments/Updates
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech mRNA Vaccines Product and Services
2.4.4 BioNTech mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 BioNTech Recent Developments/Updates
2.5 Sangamo Therapeutics
2.5.1 Sangamo Therapeutics Details
2.5.2 Sangamo Therapeutics Major Business
2.5.3 Sangamo Therapeutics mRNA Vaccines Product and Services
2.5.4 Sangamo Therapeutics mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sangamo Therapeutics Recent Developments/Updates
2.6 Argos Therapeutics
2.6.1 Argos Therapeutics Details
2.6.2 Argos Therapeutics Major Business
2.6.3 Argos Therapeutics mRNA Vaccines Product and Services
2.6.4 Argos Therapeutics mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Argos Therapeutics Recent Developments/Updates
2.7 In-Cell-Art
2.7.1 In-Cell-Art Details
2.7.2 In-Cell-Art Major Business
2.7.3 In-Cell-Art mRNA Vaccines Product and Services
2.7.4 In-Cell-Art mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 In-Cell-Art Recent Developments/Updates
2.8 eTheRNA immunotherapies
2.8.1 eTheRNA immunotherapies Details
2.8.2 eTheRNA immunotherapies Major Business
2.8.3 eTheRNA immunotherapies mRNA Vaccines Product and Services
2.8.4 eTheRNA immunotherapies mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 eTheRNA immunotherapies Recent Developments/Updates
2.9 Ethris
2.9.1 Ethris Details
2.9.2 Ethris Major Business
2.9.3 Ethris mRNA Vaccines Product and Services
2.9.4 Ethris mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Ethris Recent Developments/Updates
2.10 Tiba Biotechnology
2.10.1 Tiba Biotechnology Details
2.10.2 Tiba Biotechnology Major Business
2.10.3 Tiba Biotechnology mRNA Vaccines Product and Services
2.10.4 Tiba Biotechnology mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Tiba Biotechnology Recent Developments/Updates
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer mRNA Vaccines Product and Services
2.11.4 Pfizer mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Pfizer Recent Developments/Updates
2.12 Arcturus Therapeutics
2.12.1 Arcturus Therapeutics Details
2.12.2 Arcturus Therapeutics Major Business
2.12.3 Arcturus Therapeutics mRNA Vaccines Product and Services
2.12.4 Arcturus Therapeutics mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Arcturus Therapeutics Recent Developments/Updates
2.13 Genexine
2.13.1 Genexine Details
2.13.2 Genexine Major Business
2.13.3 Genexine mRNA Vaccines Product and Services
2.13.4 Genexine mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Genexine Recent Developments/Updates
2.14 Translate Bio
2.14.1 Translate Bio Details
2.14.2 Translate Bio Major Business
2.14.3 Translate Bio mRNA Vaccines Product and Services
2.14.4 Translate Bio mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Translate Bio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MRNA VACCINES BY MANUFACTURER
3.1 Global mRNA Vaccines Sales Quantity by Manufacturer (2021-2026)
3.2 Global mRNA Vaccines Revenue by Manufacturer (2021-2026)
3.3 Global mRNA Vaccines Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of mRNA Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 mRNA Vaccines Manufacturer Market Share in 2025
3.4.3 Top 6 mRNA Vaccines Manufacturer Market Share in 2025
3.5 mRNA Vaccines Market: Overall Company Footprint Analysis
3.5.1 mRNA Vaccines Market: Region Footprint
3.5.2 mRNA Vaccines Market: Company Product Type Footprint
3.5.3 mRNA Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global mRNA Vaccines Market Size by Region
4.1.1 Global mRNA Vaccines Sales Quantity by Region (2021-2032)
4.1.2 Global mRNA Vaccines Consumption Value by Region (2021-2032)
4.1.3 Global mRNA Vaccines Average Price by Region (2021-2032)
4.2 North America mRNA Vaccines Consumption Value (2021-2032)
4.3 Europe mRNA Vaccines Consumption Value (2021-2032)
4.4 Asia-Pacific mRNA Vaccines Consumption Value (2021-2032)
4.5 South America mRNA Vaccines Consumption Value (2021-2032)
4.6 Middle East & Africa mRNA Vaccines Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global mRNA Vaccines Sales Quantity by Type (2021-2032)
5.2 Global mRNA Vaccines Consumption Value by Type (2021-2032)
5.3 Global mRNA Vaccines Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global mRNA Vaccines Sales Quantity by Application (2021-2032)
6.2 Global mRNA Vaccines Consumption Value by Application (2021-2032)
6.3 Global mRNA Vaccines Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America mRNA Vaccines Sales Quantity by Type (2021-2032)
7.2 North America mRNA Vaccines Sales Quantity by Application (2021-2032)
7.3 North America mRNA Vaccines Market Size by Country
7.3.1 North America mRNA Vaccines Sales Quantity by Country (2021-2032)
7.3.2 North America mRNA Vaccines Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe mRNA Vaccines Sales Quantity by Type (2021-2032)
8.2 Europe mRNA Vaccines Sales Quantity by Application (2021-2032)
8.3 Europe mRNA Vaccines Market Size by Country
8.3.1 Europe mRNA Vaccines Sales Quantity by Country (2021-2032)
8.3.2 Europe mRNA Vaccines Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific mRNA Vaccines Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific mRNA Vaccines Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific mRNA Vaccines Market Size by Region
9.3.1 Asia-Pacific mRNA Vaccines Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific mRNA Vaccines Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America mRNA Vaccines Sales Quantity by Type (2021-2032)
10.2 South America mRNA Vaccines Sales Quantity by Application (2021-2032)
10.3 South America mRNA Vaccines Market Size by Country
10.3.1 South America mRNA Vaccines Sales Quantity by Country (2021-2032)
10.3.2 South America mRNA Vaccines Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa mRNA Vaccines Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa mRNA Vaccines Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa mRNA Vaccines Market Size by Country
11.3.1 Middle East & Africa mRNA Vaccines Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa mRNA Vaccines Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 mRNA Vaccines Market Drivers
12.2 mRNA Vaccines Market Restraints
12.3 mRNA Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of mRNA Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of mRNA Vaccines
13.3 mRNA Vaccines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 mRNA Vaccines Typical Distributors
14.3 mRNA Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global mRNA Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Conventional mRNA
1.3.3 Self-amplifying mRNA
1.3.4 Trans-amplifying mRNA
1.3.5 Circular mRNA
1.4 Market Analysis by Platform Approach
1.4.1 Overview: Global mRNA Vaccines Consumption Value by Platform Approach: 2021 Versus 2025 Versus 2032
1.4.2 Standard IVT Platform Vaccines
1.4.3 Modular Platform Vaccines
1.4.4 Lyophilized mRNA Vaccines
1.5 Market Analysis by Antigen Strategy
1.5.1 Overview: Global mRNA Vaccines Consumption Value by Antigen Strategy: 2021 Versus 2025 Versus 2032
1.5.2 Single-antigen Vaccines
1.5.3 Multivalent Vaccines
1.5.4 Personalized Vaccines
1.6 Market Analysis by Application
1.6.1 Overview: Global mRNA Vaccines Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Infectious Diseases
1.6.3 Autoimmune Diseases
1.6.4 Cancers
1.6.5 Others
1.7 Global mRNA Vaccines Market Size & Forecast
1.7.1 Global mRNA Vaccines Consumption Value (2021 & 2025 & 2032)
1.7.2 Global mRNA Vaccines Sales Quantity (2021-2032)
1.7.3 Global mRNA Vaccines Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Moderna
2.1.1 Moderna Details
2.1.2 Moderna Major Business
2.1.3 Moderna mRNA Vaccines Product and Services
2.1.4 Moderna mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Moderna Recent Developments/Updates
2.2 CureVac
2.2.1 CureVac Details
2.2.2 CureVac Major Business
2.2.3 CureVac mRNA Vaccines Product and Services
2.2.4 CureVac mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 CureVac Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi mRNA Vaccines Product and Services
2.3.4 Sanofi mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sanofi Recent Developments/Updates
2.4 BioNTech
2.4.1 BioNTech Details
2.4.2 BioNTech Major Business
2.4.3 BioNTech mRNA Vaccines Product and Services
2.4.4 BioNTech mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 BioNTech Recent Developments/Updates
2.5 Sangamo Therapeutics
2.5.1 Sangamo Therapeutics Details
2.5.2 Sangamo Therapeutics Major Business
2.5.3 Sangamo Therapeutics mRNA Vaccines Product and Services
2.5.4 Sangamo Therapeutics mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sangamo Therapeutics Recent Developments/Updates
2.6 Argos Therapeutics
2.6.1 Argos Therapeutics Details
2.6.2 Argos Therapeutics Major Business
2.6.3 Argos Therapeutics mRNA Vaccines Product and Services
2.6.4 Argos Therapeutics mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Argos Therapeutics Recent Developments/Updates
2.7 In-Cell-Art
2.7.1 In-Cell-Art Details
2.7.2 In-Cell-Art Major Business
2.7.3 In-Cell-Art mRNA Vaccines Product and Services
2.7.4 In-Cell-Art mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 In-Cell-Art Recent Developments/Updates
2.8 eTheRNA immunotherapies
2.8.1 eTheRNA immunotherapies Details
2.8.2 eTheRNA immunotherapies Major Business
2.8.3 eTheRNA immunotherapies mRNA Vaccines Product and Services
2.8.4 eTheRNA immunotherapies mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 eTheRNA immunotherapies Recent Developments/Updates
2.9 Ethris
2.9.1 Ethris Details
2.9.2 Ethris Major Business
2.9.3 Ethris mRNA Vaccines Product and Services
2.9.4 Ethris mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Ethris Recent Developments/Updates
2.10 Tiba Biotechnology
2.10.1 Tiba Biotechnology Details
2.10.2 Tiba Biotechnology Major Business
2.10.3 Tiba Biotechnology mRNA Vaccines Product and Services
2.10.4 Tiba Biotechnology mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Tiba Biotechnology Recent Developments/Updates
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer mRNA Vaccines Product and Services
2.11.4 Pfizer mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Pfizer Recent Developments/Updates
2.12 Arcturus Therapeutics
2.12.1 Arcturus Therapeutics Details
2.12.2 Arcturus Therapeutics Major Business
2.12.3 Arcturus Therapeutics mRNA Vaccines Product and Services
2.12.4 Arcturus Therapeutics mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Arcturus Therapeutics Recent Developments/Updates
2.13 Genexine
2.13.1 Genexine Details
2.13.2 Genexine Major Business
2.13.3 Genexine mRNA Vaccines Product and Services
2.13.4 Genexine mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Genexine Recent Developments/Updates
2.14 Translate Bio
2.14.1 Translate Bio Details
2.14.2 Translate Bio Major Business
2.14.3 Translate Bio mRNA Vaccines Product and Services
2.14.4 Translate Bio mRNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Translate Bio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MRNA VACCINES BY MANUFACTURER
3.1 Global mRNA Vaccines Sales Quantity by Manufacturer (2021-2026)
3.2 Global mRNA Vaccines Revenue by Manufacturer (2021-2026)
3.3 Global mRNA Vaccines Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of mRNA Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 mRNA Vaccines Manufacturer Market Share in 2025
3.4.3 Top 6 mRNA Vaccines Manufacturer Market Share in 2025
3.5 mRNA Vaccines Market: Overall Company Footprint Analysis
3.5.1 mRNA Vaccines Market: Region Footprint
3.5.2 mRNA Vaccines Market: Company Product Type Footprint
3.5.3 mRNA Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global mRNA Vaccines Market Size by Region
4.1.1 Global mRNA Vaccines Sales Quantity by Region (2021-2032)
4.1.2 Global mRNA Vaccines Consumption Value by Region (2021-2032)
4.1.3 Global mRNA Vaccines Average Price by Region (2021-2032)
4.2 North America mRNA Vaccines Consumption Value (2021-2032)
4.3 Europe mRNA Vaccines Consumption Value (2021-2032)
4.4 Asia-Pacific mRNA Vaccines Consumption Value (2021-2032)
4.5 South America mRNA Vaccines Consumption Value (2021-2032)
4.6 Middle East & Africa mRNA Vaccines Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global mRNA Vaccines Sales Quantity by Type (2021-2032)
5.2 Global mRNA Vaccines Consumption Value by Type (2021-2032)
5.3 Global mRNA Vaccines Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global mRNA Vaccines Sales Quantity by Application (2021-2032)
6.2 Global mRNA Vaccines Consumption Value by Application (2021-2032)
6.3 Global mRNA Vaccines Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America mRNA Vaccines Sales Quantity by Type (2021-2032)
7.2 North America mRNA Vaccines Sales Quantity by Application (2021-2032)
7.3 North America mRNA Vaccines Market Size by Country
7.3.1 North America mRNA Vaccines Sales Quantity by Country (2021-2032)
7.3.2 North America mRNA Vaccines Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe mRNA Vaccines Sales Quantity by Type (2021-2032)
8.2 Europe mRNA Vaccines Sales Quantity by Application (2021-2032)
8.3 Europe mRNA Vaccines Market Size by Country
8.3.1 Europe mRNA Vaccines Sales Quantity by Country (2021-2032)
8.3.2 Europe mRNA Vaccines Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific mRNA Vaccines Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific mRNA Vaccines Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific mRNA Vaccines Market Size by Region
9.3.1 Asia-Pacific mRNA Vaccines Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific mRNA Vaccines Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America mRNA Vaccines Sales Quantity by Type (2021-2032)
10.2 South America mRNA Vaccines Sales Quantity by Application (2021-2032)
10.3 South America mRNA Vaccines Market Size by Country
10.3.1 South America mRNA Vaccines Sales Quantity by Country (2021-2032)
10.3.2 South America mRNA Vaccines Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa mRNA Vaccines Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa mRNA Vaccines Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa mRNA Vaccines Market Size by Country
11.3.1 Middle East & Africa mRNA Vaccines Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa mRNA Vaccines Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 mRNA Vaccines Market Drivers
12.2 mRNA Vaccines Market Restraints
12.3 mRNA Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of mRNA Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of mRNA Vaccines
13.3 mRNA Vaccines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 mRNA Vaccines Typical Distributors
14.3 mRNA Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global mRNA Vaccines Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global mRNA Vaccines Consumption Value by Platform Approach, (USD Million), 2021 & 2025 & 2032
Table 3. Global mRNA Vaccines Consumption Value by Antigen Strategy, (USD Million), 2021 & 2025 & 2032
Table 4. Global mRNA Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Moderna Basic Information, Manufacturing Base and Competitors
Table 6. Moderna Major Business
Table 7. Moderna mRNA Vaccines Product and Services
Table 8. Moderna mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Moderna Recent Developments/Updates
Table 10. CureVac Basic Information, Manufacturing Base and Competitors
Table 11. CureVac Major Business
Table 12. CureVac mRNA Vaccines Product and Services
Table 13. CureVac mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. CureVac Recent Developments/Updates
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi mRNA Vaccines Product and Services
Table 18. Sanofi mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Sanofi Recent Developments/Updates
Table 20. BioNTech Basic Information, Manufacturing Base and Competitors
Table 21. BioNTech Major Business
Table 22. BioNTech mRNA Vaccines Product and Services
Table 23. BioNTech mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. BioNTech Recent Developments/Updates
Table 25. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 26. Sangamo Therapeutics Major Business
Table 27. Sangamo Therapeutics mRNA Vaccines Product and Services
Table 28. Sangamo Therapeutics mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Sangamo Therapeutics Recent Developments/Updates
Table 30. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 31. Argos Therapeutics Major Business
Table 32. Argos Therapeutics mRNA Vaccines Product and Services
Table 33. Argos Therapeutics mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Argos Therapeutics Recent Developments/Updates
Table 35. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 36. In-Cell-Art Major Business
Table 37. In-Cell-Art mRNA Vaccines Product and Services
Table 38. In-Cell-Art mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. In-Cell-Art Recent Developments/Updates
Table 40. eTheRNA immunotherapies Basic Information, Manufacturing Base and Competitors
Table 41. eTheRNA immunotherapies Major Business
Table 42. eTheRNA immunotherapies mRNA Vaccines Product and Services
Table 43. eTheRNA immunotherapies mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. eTheRNA immunotherapies Recent Developments/Updates
Table 45. Ethris Basic Information, Manufacturing Base and Competitors
Table 46. Ethris Major Business
Table 47. Ethris mRNA Vaccines Product and Services
Table 48. Ethris mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Ethris Recent Developments/Updates
Table 50. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 51. Tiba Biotechnology Major Business
Table 52. Tiba Biotechnology mRNA Vaccines Product and Services
Table 53. Tiba Biotechnology mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Tiba Biotechnology Recent Developments/Updates
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Major Business
Table 57. Pfizer mRNA Vaccines Product and Services
Table 58. Pfizer mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Pfizer Recent Developments/Updates
Table 60. Arcturus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 61. Arcturus Therapeutics Major Business
Table 62. Arcturus Therapeutics mRNA Vaccines Product and Services
Table 63. Arcturus Therapeutics mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Arcturus Therapeutics Recent Developments/Updates
Table 65. Genexine Basic Information, Manufacturing Base and Competitors
Table 66. Genexine Major Business
Table 67. Genexine mRNA Vaccines Product and Services
Table 68. Genexine mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Genexine Recent Developments/Updates
Table 70. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 71. Translate Bio Major Business
Table 72. Translate Bio mRNA Vaccines Product and Services
Table 73. Translate Bio mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Translate Bio Recent Developments/Updates
Table 75. Global mRNA Vaccines Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 76. Global mRNA Vaccines Revenue by Manufacturer (2021-2026) & (USD Million)
Table 77. Global mRNA Vaccines Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 78. Market Position of Manufacturers in mRNA Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 79. Head Office and mRNA Vaccines Production Site of Key Manufacturer
Table 80. mRNA Vaccines Market: Company Product Type Footprint
Table 81. mRNA Vaccines Market: Company Product Application Footprint
Table 82. mRNA Vaccines New Market Entrants and Barriers to Market Entry
Table 83. mRNA Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global mRNA Vaccines Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 85. Global mRNA Vaccines Sales Quantity by Region (2021-2026) & (K Dose)
Table 86. Global mRNA Vaccines Sales Quantity by Region (2027-2032) & (K Dose)
Table 87. Global mRNA Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 88. Global mRNA Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 89. Global mRNA Vaccines Average Price by Region (2021-2026) & (US$/Dose)
Table 90. Global mRNA Vaccines Average Price by Region (2027-2032) & (US$/Dose)
Table 91. Global mRNA Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 92. Global mRNA Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 93. Global mRNA Vaccines Consumption Value by Type (2021-2026) & (USD Million)
Table 94. Global mRNA Vaccines Consumption Value by Type (2027-2032) & (USD Million)
Table 95. Global mRNA Vaccines Average Price by Type (2021-2026) & (US$/Dose)
Table 96. Global mRNA Vaccines Average Price by Type (2027-2032) & (US$/Dose)
Table 97. Global mRNA Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 98. Global mRNA Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 99. Global mRNA Vaccines Consumption Value by Application (2021-2026) & (USD Million)
Table 100. Global mRNA Vaccines Consumption Value by Application (2027-2032) & (USD Million)
Table 101. Global mRNA Vaccines Average Price by Application (2021-2026) & (US$/Dose)
Table 102. Global mRNA Vaccines Average Price by Application (2027-2032) & (US$/Dose)
Table 103. North America mRNA Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 104. North America mRNA Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 105. North America mRNA Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 106. North America mRNA Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 107. North America mRNA Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 108. North America mRNA Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 109. North America mRNA Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 110. North America mRNA Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 111. Europe mRNA Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 112. Europe mRNA Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 113. Europe mRNA Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 114. Europe mRNA Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 115. Europe mRNA Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 116. Europe mRNA Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 117. Europe mRNA Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 118. Europe mRNA Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Asia-Pacific mRNA Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 120. Asia-Pacific mRNA Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 121. Asia-Pacific mRNA Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 122. Asia-Pacific mRNA Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 123. Asia-Pacific mRNA Vaccines Sales Quantity by Region (2021-2026) & (K Dose)
Table 124. Asia-Pacific mRNA Vaccines Sales Quantity by Region (2027-2032) & (K Dose)
Table 125. Asia-Pacific mRNA Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 126. Asia-Pacific mRNA Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 127. South America mRNA Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 128. South America mRNA Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 129. South America mRNA Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 130. South America mRNA Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 131. South America mRNA Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 132. South America mRNA Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 133. South America mRNA Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 134. South America mRNA Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 135. Middle East & Africa mRNA Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 136. Middle East & Africa mRNA Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 137. Middle East & Africa mRNA Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 138. Middle East & Africa mRNA Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 139. Middle East & Africa mRNA Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 140. Middle East & Africa mRNA Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 141. Middle East & Africa mRNA Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 142. Middle East & Africa mRNA Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 143. mRNA Vaccines Raw Material
Table 144. Key Manufacturers of mRNA Vaccines Raw Materials
Table 145. mRNA Vaccines Typical Distributors
Table 146. mRNA Vaccines Typical Customers
Table 1. Global mRNA Vaccines Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global mRNA Vaccines Consumption Value by Platform Approach, (USD Million), 2021 & 2025 & 2032
Table 3. Global mRNA Vaccines Consumption Value by Antigen Strategy, (USD Million), 2021 & 2025 & 2032
Table 4. Global mRNA Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Moderna Basic Information, Manufacturing Base and Competitors
Table 6. Moderna Major Business
Table 7. Moderna mRNA Vaccines Product and Services
Table 8. Moderna mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Moderna Recent Developments/Updates
Table 10. CureVac Basic Information, Manufacturing Base and Competitors
Table 11. CureVac Major Business
Table 12. CureVac mRNA Vaccines Product and Services
Table 13. CureVac mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. CureVac Recent Developments/Updates
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi mRNA Vaccines Product and Services
Table 18. Sanofi mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Sanofi Recent Developments/Updates
Table 20. BioNTech Basic Information, Manufacturing Base and Competitors
Table 21. BioNTech Major Business
Table 22. BioNTech mRNA Vaccines Product and Services
Table 23. BioNTech mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. BioNTech Recent Developments/Updates
Table 25. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 26. Sangamo Therapeutics Major Business
Table 27. Sangamo Therapeutics mRNA Vaccines Product and Services
Table 28. Sangamo Therapeutics mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Sangamo Therapeutics Recent Developments/Updates
Table 30. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 31. Argos Therapeutics Major Business
Table 32. Argos Therapeutics mRNA Vaccines Product and Services
Table 33. Argos Therapeutics mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Argos Therapeutics Recent Developments/Updates
Table 35. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 36. In-Cell-Art Major Business
Table 37. In-Cell-Art mRNA Vaccines Product and Services
Table 38. In-Cell-Art mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. In-Cell-Art Recent Developments/Updates
Table 40. eTheRNA immunotherapies Basic Information, Manufacturing Base and Competitors
Table 41. eTheRNA immunotherapies Major Business
Table 42. eTheRNA immunotherapies mRNA Vaccines Product and Services
Table 43. eTheRNA immunotherapies mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. eTheRNA immunotherapies Recent Developments/Updates
Table 45. Ethris Basic Information, Manufacturing Base and Competitors
Table 46. Ethris Major Business
Table 47. Ethris mRNA Vaccines Product and Services
Table 48. Ethris mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Ethris Recent Developments/Updates
Table 50. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 51. Tiba Biotechnology Major Business
Table 52. Tiba Biotechnology mRNA Vaccines Product and Services
Table 53. Tiba Biotechnology mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Tiba Biotechnology Recent Developments/Updates
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Major Business
Table 57. Pfizer mRNA Vaccines Product and Services
Table 58. Pfizer mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Pfizer Recent Developments/Updates
Table 60. Arcturus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 61. Arcturus Therapeutics Major Business
Table 62. Arcturus Therapeutics mRNA Vaccines Product and Services
Table 63. Arcturus Therapeutics mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Arcturus Therapeutics Recent Developments/Updates
Table 65. Genexine Basic Information, Manufacturing Base and Competitors
Table 66. Genexine Major Business
Table 67. Genexine mRNA Vaccines Product and Services
Table 68. Genexine mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Genexine Recent Developments/Updates
Table 70. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 71. Translate Bio Major Business
Table 72. Translate Bio mRNA Vaccines Product and Services
Table 73. Translate Bio mRNA Vaccines Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Translate Bio Recent Developments/Updates
Table 75. Global mRNA Vaccines Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 76. Global mRNA Vaccines Revenue by Manufacturer (2021-2026) & (USD Million)
Table 77. Global mRNA Vaccines Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 78. Market Position of Manufacturers in mRNA Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 79. Head Office and mRNA Vaccines Production Site of Key Manufacturer
Table 80. mRNA Vaccines Market: Company Product Type Footprint
Table 81. mRNA Vaccines Market: Company Product Application Footprint
Table 82. mRNA Vaccines New Market Entrants and Barriers to Market Entry
Table 83. mRNA Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global mRNA Vaccines Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 85. Global mRNA Vaccines Sales Quantity by Region (2021-2026) & (K Dose)
Table 86. Global mRNA Vaccines Sales Quantity by Region (2027-2032) & (K Dose)
Table 87. Global mRNA Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 88. Global mRNA Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 89. Global mRNA Vaccines Average Price by Region (2021-2026) & (US$/Dose)
Table 90. Global mRNA Vaccines Average Price by Region (2027-2032) & (US$/Dose)
Table 91. Global mRNA Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 92. Global mRNA Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 93. Global mRNA Vaccines Consumption Value by Type (2021-2026) & (USD Million)
Table 94. Global mRNA Vaccines Consumption Value by Type (2027-2032) & (USD Million)
Table 95. Global mRNA Vaccines Average Price by Type (2021-2026) & (US$/Dose)
Table 96. Global mRNA Vaccines Average Price by Type (2027-2032) & (US$/Dose)
Table 97. Global mRNA Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 98. Global mRNA Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 99. Global mRNA Vaccines Consumption Value by Application (2021-2026) & (USD Million)
Table 100. Global mRNA Vaccines Consumption Value by Application (2027-2032) & (USD Million)
Table 101. Global mRNA Vaccines Average Price by Application (2021-2026) & (US$/Dose)
Table 102. Global mRNA Vaccines Average Price by Application (2027-2032) & (US$/Dose)
Table 103. North America mRNA Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 104. North America mRNA Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 105. North America mRNA Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 106. North America mRNA Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 107. North America mRNA Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 108. North America mRNA Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 109. North America mRNA Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 110. North America mRNA Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 111. Europe mRNA Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 112. Europe mRNA Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 113. Europe mRNA Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 114. Europe mRNA Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 115. Europe mRNA Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 116. Europe mRNA Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 117. Europe mRNA Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 118. Europe mRNA Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 119. Asia-Pacific mRNA Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 120. Asia-Pacific mRNA Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 121. Asia-Pacific mRNA Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 122. Asia-Pacific mRNA Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 123. Asia-Pacific mRNA Vaccines Sales Quantity by Region (2021-2026) & (K Dose)
Table 124. Asia-Pacific mRNA Vaccines Sales Quantity by Region (2027-2032) & (K Dose)
Table 125. Asia-Pacific mRNA Vaccines Consumption Value by Region (2021-2026) & (USD Million)
Table 126. Asia-Pacific mRNA Vaccines Consumption Value by Region (2027-2032) & (USD Million)
Table 127. South America mRNA Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 128. South America mRNA Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 129. South America mRNA Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 130. South America mRNA Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 131. South America mRNA Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 132. South America mRNA Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 133. South America mRNA Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 134. South America mRNA Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 135. Middle East & Africa mRNA Vaccines Sales Quantity by Type (2021-2026) & (K Dose)
Table 136. Middle East & Africa mRNA Vaccines Sales Quantity by Type (2027-2032) & (K Dose)
Table 137. Middle East & Africa mRNA Vaccines Sales Quantity by Application (2021-2026) & (K Dose)
Table 138. Middle East & Africa mRNA Vaccines Sales Quantity by Application (2027-2032) & (K Dose)
Table 139. Middle East & Africa mRNA Vaccines Sales Quantity by Country (2021-2026) & (K Dose)
Table 140. Middle East & Africa mRNA Vaccines Sales Quantity by Country (2027-2032) & (K Dose)
Table 141. Middle East & Africa mRNA Vaccines Consumption Value by Country (2021-2026) & (USD Million)
Table 142. Middle East & Africa mRNA Vaccines Consumption Value by Country (2027-2032) & (USD Million)
Table 143. mRNA Vaccines Raw Material
Table 144. Key Manufacturers of mRNA Vaccines Raw Materials
Table 145. mRNA Vaccines Typical Distributors
Table 146. mRNA Vaccines Typical Customers
LIST OF FIGURES
Figure 1. mRNA Vaccines Picture
Figure 2. Global mRNA Vaccines Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global mRNA Vaccines Revenue Market Share by Type in 2025
Figure 4. Conventional mRNA Examples
Figure 5. Self-amplifying mRNA Examples
Figure 6. Trans-amplifying mRNA Examples
Figure 7. Circular mRNA Examples
Figure 8. Global mRNA Vaccines Revenue by Platform Approach, (USD Million), 2021 & 2025 & 2032
Figure 9. Global mRNA Vaccines Revenue Market Share by Platform Approach in 2025
Figure 10. Standard IVT Platform Vaccines Examples
Figure 11. Modular Platform Vaccines Examples
Figure 12. Lyophilized mRNA Vaccines Examples
Figure 13. Global mRNA Vaccines Revenue by Antigen Strategy, (USD Million), 2021 & 2025 & 2032
Figure 14. Global mRNA Vaccines Revenue Market Share by Antigen Strategy in 2025
Figure 15. Single-antigen Vaccines Examples
Figure 16. Multivalent Vaccines Examples
Figure 17. Personalized Vaccines Examples
Figure 18. Global mRNA Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Global mRNA Vaccines Revenue Market Share by Application in 2025
Figure 20. Infectious Diseases Examples
Figure 21. Autoimmune Diseases Examples
Figure 22. Cancers Examples
Figure 23. Others Examples
Figure 24. Global mRNA Vaccines Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global mRNA Vaccines Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global mRNA Vaccines Sales Quantity (2021-2032) & (K Dose)
Figure 27. Global mRNA Vaccines Price (2021-2032) & (US$/Dose)
Figure 28. Global mRNA Vaccines Sales Quantity Market Share by Manufacturer in 2025
Figure 29. Global mRNA Vaccines Revenue Market Share by Manufacturer in 2025
Figure 30. Producer Shipments of mRNA Vaccines by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 31. Top 3 mRNA Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 32. Top 6 mRNA Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 33. Global mRNA Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 34. Global mRNA Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 35. North America mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 37. Asia-Pacific mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 38. South America mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 39. Middle East & Africa mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 40. Global mRNA Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 41. Global mRNA Vaccines Consumption Value Market Share by Type (2021-2032)
Figure 42. Global mRNA Vaccines Average Price by Type (2021-2032) & (US$/Dose)
Figure 43. Global mRNA Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 44. Global mRNA Vaccines Revenue Market Share by Application (2021-2032)
Figure 45. Global mRNA Vaccines Average Price by Application (2021-2032) & (US$/Dose)
Figure 46. North America mRNA Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 47. North America mRNA Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 48. North America mRNA Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 49. North America mRNA Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 50. United States mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe mRNA Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 54. Europe mRNA Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 55. Europe mRNA Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 56. Europe mRNA Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 58. France mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific mRNA Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 63. Asia-Pacific mRNA Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 64. Asia-Pacific mRNA Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 65. Asia-Pacific mRNA Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 66. China mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 69. India mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 72. South America mRNA Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 73. South America mRNA Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 74. South America mRNA Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 75. South America mRNA Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 76. Brazil mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 77. Argentina mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 78. Middle East & Africa mRNA Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 79. Middle East & Africa mRNA Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 80. Middle East & Africa mRNA Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 81. Middle East & Africa mRNA Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 82. Turkey mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 83. Egypt mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 85. South Africa mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 86. mRNA Vaccines Market Drivers
Figure 87. mRNA Vaccines Market Restraints
Figure 88. mRNA Vaccines Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. Manufacturing Cost Structure Analysis of mRNA Vaccines in 2025
Figure 91. Manufacturing Process Analysis of mRNA Vaccines
Figure 92. mRNA Vaccines Industrial Chain
Figure 93. Sales Channel: Direct to End-User vs Distributors
Figure 94. Direct Channel Pros & Cons
Figure 95. Indirect Channel Pros & Cons
Figure 96. Methodology
Figure 97. Research Process and Data Source
Figure 1. mRNA Vaccines Picture
Figure 2. Global mRNA Vaccines Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global mRNA Vaccines Revenue Market Share by Type in 2025
Figure 4. Conventional mRNA Examples
Figure 5. Self-amplifying mRNA Examples
Figure 6. Trans-amplifying mRNA Examples
Figure 7. Circular mRNA Examples
Figure 8. Global mRNA Vaccines Revenue by Platform Approach, (USD Million), 2021 & 2025 & 2032
Figure 9. Global mRNA Vaccines Revenue Market Share by Platform Approach in 2025
Figure 10. Standard IVT Platform Vaccines Examples
Figure 11. Modular Platform Vaccines Examples
Figure 12. Lyophilized mRNA Vaccines Examples
Figure 13. Global mRNA Vaccines Revenue by Antigen Strategy, (USD Million), 2021 & 2025 & 2032
Figure 14. Global mRNA Vaccines Revenue Market Share by Antigen Strategy in 2025
Figure 15. Single-antigen Vaccines Examples
Figure 16. Multivalent Vaccines Examples
Figure 17. Personalized Vaccines Examples
Figure 18. Global mRNA Vaccines Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Global mRNA Vaccines Revenue Market Share by Application in 2025
Figure 20. Infectious Diseases Examples
Figure 21. Autoimmune Diseases Examples
Figure 22. Cancers Examples
Figure 23. Others Examples
Figure 24. Global mRNA Vaccines Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global mRNA Vaccines Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global mRNA Vaccines Sales Quantity (2021-2032) & (K Dose)
Figure 27. Global mRNA Vaccines Price (2021-2032) & (US$/Dose)
Figure 28. Global mRNA Vaccines Sales Quantity Market Share by Manufacturer in 2025
Figure 29. Global mRNA Vaccines Revenue Market Share by Manufacturer in 2025
Figure 30. Producer Shipments of mRNA Vaccines by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 31. Top 3 mRNA Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 32. Top 6 mRNA Vaccines Manufacturer (Revenue) Market Share in 2025
Figure 33. Global mRNA Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 34. Global mRNA Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 35. North America mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 36. Europe mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 37. Asia-Pacific mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 38. South America mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 39. Middle East & Africa mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 40. Global mRNA Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 41. Global mRNA Vaccines Consumption Value Market Share by Type (2021-2032)
Figure 42. Global mRNA Vaccines Average Price by Type (2021-2032) & (US$/Dose)
Figure 43. Global mRNA Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 44. Global mRNA Vaccines Revenue Market Share by Application (2021-2032)
Figure 45. Global mRNA Vaccines Average Price by Application (2021-2032) & (US$/Dose)
Figure 46. North America mRNA Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 47. North America mRNA Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 48. North America mRNA Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 49. North America mRNA Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 50. United States mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 51. Canada mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 52. Mexico mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe mRNA Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 54. Europe mRNA Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 55. Europe mRNA Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 56. Europe mRNA Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 58. France mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific mRNA Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 63. Asia-Pacific mRNA Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 64. Asia-Pacific mRNA Vaccines Sales Quantity Market Share by Region (2021-2032)
Figure 65. Asia-Pacific mRNA Vaccines Consumption Value Market Share by Region (2021-2032)
Figure 66. China mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 69. India mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 72. South America mRNA Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 73. South America mRNA Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 74. South America mRNA Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 75. South America mRNA Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 76. Brazil mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 77. Argentina mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 78. Middle East & Africa mRNA Vaccines Sales Quantity Market Share by Type (2021-2032)
Figure 79. Middle East & Africa mRNA Vaccines Sales Quantity Market Share by Application (2021-2032)
Figure 80. Middle East & Africa mRNA Vaccines Sales Quantity Market Share by Country (2021-2032)
Figure 81. Middle East & Africa mRNA Vaccines Consumption Value Market Share by Country (2021-2032)
Figure 82. Turkey mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 83. Egypt mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 84. Saudi Arabia mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 85. South Africa mRNA Vaccines Consumption Value (2021-2032) & (USD Million)
Figure 86. mRNA Vaccines Market Drivers
Figure 87. mRNA Vaccines Market Restraints
Figure 88. mRNA Vaccines Market Trends
Figure 89. Porters Five Forces Analysis
Figure 90. Manufacturing Cost Structure Analysis of mRNA Vaccines in 2025
Figure 91. Manufacturing Process Analysis of mRNA Vaccines
Figure 92. mRNA Vaccines Industrial Chain
Figure 93. Sales Channel: Direct to End-User vs Distributors
Figure 94. Direct Channel Pros & Cons
Figure 95. Indirect Channel Pros & Cons
Figure 96. Methodology
Figure 97. Research Process and Data Source
